Takara Bio Inc.
Investor Relations
Financial Data
Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Financial Highlights（Quarterly）

Net Sales

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	35,841	34,565	46,086	67,699	78,142	43,505
3Q	25,888	24,558	29,549	45,659	60,206	29,734
2Q	17,370	16,450	17,393	31,551	32,587	19,116
1Q	8,847	8,650	6,938	15,272	14,102	9,176

Operating Income

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	5,463	6,274	13,952	28,902	20,541	3,003
3Q	3,432	3,879	8,791	19,926	19,403	336
2Q	2,623	3,035	3,736	14,105	10,870	1,410
1Q	1,544	2,251	693	8,504	4,537	423

Ordinary Income

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	5,665	6,347	14,159	28,459	20,682	3,405
3Q	3,549	3,896	8,919	20,154	19,480	586
2Q	2,669	2,961	3,820	14,241	10,955	1,598
1Q	1,559	2,200	745	8,579	4,593	509

Profit Attributable to Owners of Parent

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	3,657	3,819	9,547	19,849	16,012	1,480
3Q	2,088	2,708	5,726	14,364	14,595	154
2Q	1,720	2,075	2,274	10,009	8,538	1,084
1Q	1,032	1,591	404	6,025	3,907	319

Net Income Per Share

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	30.38	31.72	79.29	164.84	132.97	12.30
3Q	17.35	22.49	47.56	119.29	121.21	1.28
2Q	14.29	17.23	18.89	83.12	70.91	9.00
1Q	8.57	13.22	3.36	50.04	32.45	2.65

Total Assets

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	71,040	75,009	89,750	115,712	129,202	121,252
3Q	70,705	71,835	83,846	106,116	128,140	123,087
2Q	68,677	70,837	77,343	104,777	120,023	123,283
1Q	67,643	71,402	73,593	99,658	111,488	120,662

Net Assets

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	64,095	66,591	74,302	96,064	112,454	111,784
3Q	63,193	64,888	70,568	89,455	114,711	112,529
2Q	62,267	64,558	67,236	84,766	106,949	112,130
1Q	60,921	65,154	65,580	80,586	98,425	108,207

Capital Adequacy Ratio

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
FY	90.1	88.7	82.7	82.9	86.9	92.0
3Q	89.2	90.2	84.0	84.1	89.3	91.2
2Q	90.5	91.0	86.8	80.7	88.9	90.7
1Q	89.9	91.1	89.0	80.7	88.1	89.5

CLOSE
MENU

サイト内検索

footer-content

menu

JA
EN

contact

gnavi-box